We have made important advancements in treatment, but are still being overwhelmed by the number of late-stage cases ...
The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...
Mass population testing for prostate cancer will not see men proactively invited for the PSA blood test - here is all you ...
John Tesh was diagnosed with prostate cancer despite having a low PSA and given 18 months to live back in 2015. Now, 10 years ...
For decades, it has been known that prostate specific antigen ‒ or PSA ‒ tests are a flawed way to diagnose prostate cancer. Many men have a high PSA without having cancer. Others have low PSA that ...
The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...
Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.
Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...
The understanding of prostate cancer has significantly evolved in the past 15 years. Therefore, many people — including primary care providers — may not be aware of the current guidelines for prostate ...
However, the UK National Screening Committee (UKNSC) has announced its draft decision to advise the government against ...
When it comes to prostate cancer, there’s a lot of confusion and guesswork floating around—especially among men who don’t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback